VBL Therapeutics Selected for €17.5 Million of Funding from Horizon Europe EIC Accelerator Program

NEXT STORY
Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)
PREV STORY
GBS Inc. to Participate in the Upcoming January Virtual Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting

author_avatar
NASDAQ Market News

Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Uplisting to Nasdaq Global Market

TEL-AVIV, Israel and RALEIGH, N.C., July 23, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News